References
- Blaney JE, Wirblich C, Papaneri AB et al. Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses. J. Virol.85(20), 10605–10616 (2011).
- Falzarano D, Geisbert TW, Feldmann H. Progress in filovirus vaccine development: evaluating the potential for clinical use. Exp. Rev. Vaccines10(1), 63–77 (2011).
- Vos A, Pommerening E, Neubert L, Kachel S, Neubert A. Safety studies of the oral rabies vaccine SAD B19 in striped skunk (Mephitis mephitis). J. Wildl. Dis.38(2), 428–431 (2002).
- Plotkin SA. Rabies vaccine prepared in human cell cultures: progress and perspectives. Rev. Infect. Dis.2(3), 433–448 (1980).
- Faber M, Lamirande EW, Roberts A et al. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies. J. Gen. Virol.86(Pt 5), 1435–1440 (2005).
- McGettigan JP, Koser ML, McKenna PM et al. Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2. Virology344(2), 363–377 (2006).
- Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr. Infect. Dis. J.20(1), 63–75 (2001).
- Gupta M, Mahanty S, Bray M, Ahmed R, Rollin PE. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. J. Virol.75(10), 4649–4654 (2001).
- Gupta M, Mahanty S, Greer P et al. Persistent infection with ebola virus under conditions of partial immunity. J. Virol.78(2), 958–967 (2004).
- Pushko P, Bray M, Ludwig GV et al. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine19(1), 142–153 (2000).
- Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg. Infect. Dis.8(5), 503–507 (2002).
- Calisher CH, Childs JE, Field HE, Holmes KV, Schountz T. Bats: important reservoir hosts of emerging viruses. Clin. Microbiol. Rev.19(3), 531–545 (2006).
- Leroy EM, Kumulungui B, Pourrut X et al. Fruit bats as reservoirs of Ebola virus. Nature438(7068), 575–576 (2005).
- Swanepoel R, Smit SB, Rollin PE et al. Studies of reservoir hosts for Marburg virus. Emerg. Infect. Dis.13(12), 1847–1851 (2007).
- Imported case of Marburg hemorrhagic fever – Colorado, 2008. MMWR Morb. Mortal. Wkly Rep.58(49), 1377–1381 (2009).
- Timen A, Koopmans MP, Vossen AC et al. Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg. Infect. Dis.15(8), 1171–1175 (2009).
- Niin E, Laine M, Guiot AL, Demerson JM, Cliquet F. Rabies in Estonia: situation before and after the first campaigns of oral vaccination of wildlife with SAG2 vaccine bait. Vaccine26(29–30), 3556–3565 (2008).
- Kobinger GP, Leung A, Neufeld J et al. Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J. Infect. Dis.204(2), 200–208 (2011).
- Cliquet F, Aubert M. Elimination of terrestrial rabies in Western European countries. Dev. Biol. (Basel)119, 185–204 (2004).
Website
- Known cases and outbreaks of Ebola hemorrhagic fever, in chronological order. www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/ebola/ebolatable.htm